PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 1, 2005Clinical and Experimental Hypertension46 citationsOpen Access

Efficacy and Duration of Action of the Four Selective Angiotensin II Subtype 1 Receptor Blockers, Losartan, Candesartan, Valsartan and Telmisartan, in Patients with Essential Hypertension Determined by Home Blood Pressure Measurements

View Full Paper
TNTakuya NishimuraJHJunichiro HashimotoTOTakayoshi Ohkubo

Structured PICO

Does the choice of ARB (losartan, candesartan, valsartan, telmisartan) affect the efficacy and 24-hour duration of blood pressure lowering in patients with essential hypertension?

P
Population
Patients over 30 years old diagnosed with essential hypertension on the basis of home blood pressure measurements.
I
Intervention
Angiotensin II receptor blockers (ARBs) taken once daily in the morning: losartan (25-100 mg), candesartan (2-12 mg), valsartan (40-80 mg), or telmisartan (10-40 mg).
C
Comparator
Active comparators (the 4 ARBs compared against each other).
O
Outcome
Efficacy on home blood pressure (SBP and DBP) and duration of BP-lowering effect using morning effect versus evening effect ratio (M/E ratio).surrogate

Telmisartan, valsartan, and candesartan provide more sustained 24-hour blood pressure control compared to losartan when dosed once daily in the morning.

Abstract

Our objective was to compare the efficacy and duration of action of 4 angiotensin II receptor blockers (ARBs)--losartan (25-100 mg), candesartan (2-12 mg), valsartan (40-80 mg), and telmisartan (10-40 mg)-in patients with essential hypertension using self-measurement of blood pressure at home (home BP) and to examine the differential effect of the four ARBs on home pulse pressure (home PP). After a 2-week run-in period, each of the 4 ARBs was assigned to subjects who were diagnosed as having hypertension on the basis of home BP and who were over 30 years old. The subjects were asked to take the ARB once daily in the morning and to measure home BP once in the evening and in the morning. We compared the efficacy of each ARB on home BP and home PP and assessed the duration of the BP-lowering effect using the morning effect versus evening effect ratio (M/E ratio). The antihypertensive effects of telmisartan on home systolic BP (SBP) both in the evening and in the morning and on home diastolic BP (DBP) in the morning were significantly greater than those of losartan. The effect of each ARB on home BP in the morning and in the evening was expressed as a ratio (M/E ratio). The M/E ratios of SBP/DBP in patients treated with losartan, candesartan, valsartan, and telmisartan were 0.49/0.16, 0.69/1.01, 0.82/0.88, and 0.88/0.88, respectively. The home PP-lowering effect was greater for valsartan and telmisartan than for losartan and candesartan in the morning. Among the 4 ARBs, the duration of the BP-lowering effect of losartan did not persist throughout 24 hr. The effects of the other 3 ARBs, in particular telmisartan, persisted over 24 hr when they were administered once daily in the morning. In addition, the duration of the PP-lowering effect was similar to that of the BP-lowering effect. Such long-acting property of several ARBs is essential for the modern antihypertensive treatment, and home BP measurements are useful for determining the duration of action of antihypertensive drugs. Losartan, 25 mg a day, which is usually used as an initial dose in Japan, is apparently insufficient to obtain adequate antihypertensive effect and sufficient duration of action.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Nishimura et al. (2005) studied this question.

synapsesocial.com/papers/6a2601cc6d0b964d16cfdd40https://doi.org/10.1081/ceh-200067668
Ask AI
Helpful
Bookmark
Share
View Full Paper